Bon TEVA
Di bawah adalah senarai bon-bon korporat Teva Pharmaceutical Industries Limited. Pelabur selalunya memilih bon syarikat kerana kestabilan meningkat mereka semasa ketidakstabilan pasaran. Kaji harga, hasil dan statistik lain dan cari pelaburan yang boleh dipercayai.
Simbol | YTM % | Harga % | Kupon % | Tarikh Matang | Jumlah tertunggak | Nilai muka | Jumlah denominasi min | Pengeluar |
|---|---|---|---|---|---|---|---|---|
| TTEVA5034099Teva Pharmaceutical Finance Netherlands III BV 7.125% 31-JAN-2025 | 7.08% | 100.04% | 7.13% | 2025-01-31 | 425.259 M USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA4608603Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | 7.00% | 99.25% | 6.75% | 2028-03-01 | 255 K USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTFACTEVA P.FI.NL III 16/46 | 6.42% | 70.13% | 4.10% | 2046-10-01 | 2 B USD | 1,000.00 USD | 2,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| UUS88167AAP6TEVA P.F.III 21/27 | 6.08% | 96.88% | 4.75% | 2027-05-09 | 1 B USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| UUS88163VAD1TEVA PHARM.FIN. 2036 | 6.07% | 100.70% | 6.15% | 2036-02-01 | 789.428 M USD | 1,000.00 USD | 2,000.00 USD | Teva Pharmaceutical Finance Co. LLC |
| TTEVA5549924Teva Pharmaceutical Finance Netherlands III BV 8.125% 15-SEP-2031 | 6.01% | 112.03% | 8.13% | 2031-09-15 | 500 M USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA4608604Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | 5.96% | 102.38% | 6.75% | 2028-03-01 | 1.25 B USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTFABTEVA P.FI.NL III 16/26 | 5.91% | 95.00% | 3.15% | 2026-10-01 | 3.378 B USD | 1,000.00 USD | 2,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5549923Teva Pharmaceutical Finance Netherlands III BV 7.875% 15-SEP-2029 | 5.90% | 108.40% | 7.88% | 2029-09-15 | 600 M USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| UUS88167AAQ4TEVA P.F.III 21/29 | 5.88% | 96.98% | 5.13% | 2029-05-09 | 1 B USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA4914602Teva Pharmaceutical Finance Netherlands III BV 7.125% 31-JAN-2025 | 5.84% | 101.25% | 7.13% | 2025-01-31 | 1.255 M USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| XXS219821395TEVA PHARM FINANCE NL II 6% GTD SNR NTS 31/01/2025 EUR100000 | 5.82% | 100.18% | 6.00% | 2025-01-31 | 410.607 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS259280419TEV.P.F.N.II 23/31 | 4.62% | 119.32% | 7.88% | 2031-09-15 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS181372460TEVA PH.F.NL.II 18/25 | 4.54% | 99.96% | 4.50% | 2025-03-01 | 494.346 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS240660717TEV.P.F.N.II 21/30 | 4.51% | 99.34% | 4.38% | 2030-05-09 | 1.5 B EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS259280443TEV.P.F.N.II 23/29 | 4.48% | 112.70% | 7.38% | 2029-09-15 | 800 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS240660709TEV.P.F.N.II 21/27 | 3.97% | 99.47% | 3.75% | 2027-05-09 | 1.1 B EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS121104407TEVA PH.F.NL.II 15/27 | 3.90% | 95.33% | 1.88% | 2027-03-31 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS143974936TEVA PH.F.NL.II 16/28 | 3.79% | 92.04% | 1.63% | 2028-10-15 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| TTEVA.GJTeva Pharmaceutical Finance Co. LLC 0.25% 01-FEB-2026 | 2.69% | 97.00% | 0.25% | 2026-02-01 | 22.879 M USD | 1,000.00 USD | 1,000.00 USD | Teva Pharmaceutical Finance Co. LLC |
| CCH33382750TEVA PH.FI.NL IV 16-25 | 2.13% | 98.89% | 1.00% | 2025-07-28 | 350 M CHF | 5,000.00 CHF | 5,000.00 CHF | Teva Pharmaceutical Finance Netherlands II BV |
| TTEVA3666246IVAX LLC 1.875% 15-DEC-2024 | — | — | 1.88% | 2024-12-15 | 333 M USD | 1,000.00 USD | 1,000.00 USD | IVAX LLC |